370 related articles for article (PubMed ID: 12016269)
21. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
Waltenberger J; Uecker A; Kroll J; Frank H; Mayr U; Bjorge JD; Fujita D; Gazit A; Hombach V; Levitzki A; Böhmer FD
Circ Res; 1999 Jul; 85(1):12-22. PubMed ID: 10400906
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of platelet-derived growth factor-induced mitogenesis by phosphodiesterase 3 inhibitors: role of protein kinase A in vascular smooth muscle cell mitogenesis.
Osinski MT; Schrör K
Biochem Pharmacol; 2000 Aug; 60(3):381-7. PubMed ID: 10856433
[TBL] [Abstract][Full Text] [Related]
23. Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery.
Zygmunt PM; Edwards G; Weston AH; Davis SC; Högestätt ED
Br J Pharmacol; 1996 Jul; 118(5):1147-52. PubMed ID: 8818337
[TBL] [Abstract][Full Text] [Related]
24. Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries. The role of heparin-sensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation.
Geary RL; Koyama N; Wang TW; Vergel S; Clowes AW
Circulation; 1995 Jun; 91(12):2972-81. PubMed ID: 7796508
[TBL] [Abstract][Full Text] [Related]
25. Histone deacetylase 4 controls neointimal hyperplasia via stimulating proliferation and migration of vascular smooth muscle cells.
Usui T; Morita T; Okada M; Yamawaki H
Hypertension; 2014 Feb; 63(2):397-403. PubMed ID: 24166750
[TBL] [Abstract][Full Text] [Related]
26. Characterization of 5,6- and 8,9-epoxyeicosatrienoic acids (5,6- and 8,9-EET) as potent in vivo angiogenic lipids.
Pozzi A; Macias-Perez I; Abair T; Wei S; Su Y; Zent R; Falck JR; Capdevila JH
J Biol Chem; 2005 Jul; 280(29):27138-46. PubMed ID: 15917237
[TBL] [Abstract][Full Text] [Related]
27. Role of cytochrome P450 2C epoxygenases in hypoxia-induced cell migration and angiogenesis in retinal endothelial cells.
Michaelis UR; Xia N; Barbosa-Sicard E; Falck JR; Fleming I
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1242-7. PubMed ID: 18326754
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase and alphavbeta3 integrin-dependent vascular smooth muscle cell invasion through a type I collagen lattice.
Kanda S; Kuzuya M; Ramos MA; Koike T; Yoshino K; Ikeda S; Iguchi A
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):998-1005. PubMed ID: 10764664
[TBL] [Abstract][Full Text] [Related]
29. Epoxyeicosatrienoic acids regulate Trp channel dependent Ca2+ signaling and hyperpolarization in endothelial cells.
Fleming I; Rueben A; Popp R; Fisslthaler B; Schrodt S; Sander A; Haendeler J; Falck JR; Morisseau C; Hammock BD; Busse R
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2612-8. PubMed ID: 17872452
[TBL] [Abstract][Full Text] [Related]
30. Aldose reductase inhibitor improves insulin-mediated glucose uptake and prevents migration of human coronary artery smooth muscle cells induced by high glucose.
Yasunari K; Kohno M; Kano H; Minami M; Yoshikawa J
Hypertension; 2000 May; 35(5):1092-8. PubMed ID: 10818070
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of intermediate-conductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle.
Tharp DL; Wamhoff BR; Turk JR; Bowles DK
Am J Physiol Heart Circ Physiol; 2006 Nov; 291(5):H2493-503. PubMed ID: 16798818
[TBL] [Abstract][Full Text] [Related]
32. Cytochrome P4502C9-derived epoxyeicosatrienoic acids induce the expression of cyclooxygenase-2 in endothelial cells.
Michaelis UR; Falck JR; Schmidt R; Busse R; Fleming I
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):321-6. PubMed ID: 15569819
[TBL] [Abstract][Full Text] [Related]
33. Prevention of vascular smooth muscle cell proliferation and injury-induced neointimal hyperplasia by CREB-mediated p21 induction: An insight from a plant polyphenol.
Sun L; Zhao R; Zhang L; Zhang W; He G; Yang S; Song J; Du G
Biochem Pharmacol; 2016 Mar; 103():40-52. PubMed ID: 26807478
[TBL] [Abstract][Full Text] [Related]
34. Epoxyeicosatrienoic acids increase intracellular calcium concentration in vascular smooth muscle cells.
Fang X; Weintraub NL; Stoll LL; Spector AA
Hypertension; 1999 Dec; 34(6):1242-6. PubMed ID: 10601125
[TBL] [Abstract][Full Text] [Related]
35. Ets-1 is an early response gene activated by ET-1 and PDGF-BB in vascular smooth muscle cells.
Naito S; Shimizu S; Maeda S; Wang J; Paul R; Fagin JA
Am J Physiol; 1998 Feb; 274(2):C472-80. PubMed ID: 9486138
[TBL] [Abstract][Full Text] [Related]
36. Endothelial nitric oxide synthase gene transfer inhibits human smooth muscle cell migration via inhibition of Rho A.
Largiadèr T; Eto M; Payeli SK; Greutert H; Viswambharan H; Lachat M; Zünd G; Yang Z; Tanner FC; Lüscher TF
J Cardiovasc Pharmacol; 2008 Oct; 52(4):369-74. PubMed ID: 18841072
[TBL] [Abstract][Full Text] [Related]
37. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.
Pukac L; Huangpu J; Karnovsky MJ
Exp Cell Res; 1998 Aug; 242(2):548-60. PubMed ID: 9683541
[TBL] [Abstract][Full Text] [Related]
38. Arachidonic acid pretreatment enhances smooth muscle cell migration via increased Ca2+ influx.
Kanayasu-Toyoda T; Morita I; Murota S
Prostaglandins Leukot Essent Fatty Acids; 1998 Jan; 58(1):25-31. PubMed ID: 9482163
[TBL] [Abstract][Full Text] [Related]
39. Role of E2F and ERK1/2 in STI571-mediated smooth muscle cell growth arrest and cyclin A transcriptional repression.
Sanz-González SM; Castro C; Pérez P; Andrés V
Biochem Biophys Res Commun; 2004 May; 317(4):972-9. PubMed ID: 15094364
[TBL] [Abstract][Full Text] [Related]
40. Antimitogenic effects of trapidil in coronary artery smooth muscle cells by direct activation of protein kinase A.
Bönisch D; Weber AA; Wittpoth M; Osinski M; Schrör K
Mol Pharmacol; 1998 Aug; 54(2):241-8. PubMed ID: 9687564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]